Technology

PSLV-C45 successfully injects EMISAT into orbit: ISRO

PSLV-C45 successfully injects EMISAT into orbit: ISRO

Technology
Updates from :  the Hindu : The EMISAT satellite is aimed at electromagnetic measurement. Indian Space Research Organisation (ISRO) launched the country's newest satellite, EMISAT, from Sriharikota launch station on Monday. The spacecraft meant to provide electronic intelligence to the Armed Forces is the first of its kind for the country. It took off on the four-stage PSLV-C45 rocket at 9.27 a.m. along with 28 small commercial satellites from the second launch pad at the spaceport of Sriharikota. EMISAT was released first 17 minutes into the launch at an orbit 749 km away. The small satellites were to be released after about 40 minutes at a lower orbit of 504 km. The countdown for the project began on Sunday on board Indian Space Research Organisation’s third generation
Power in space: on Mission Shakti

Power in space: on Mission Shakti

Technology
Updates from :  the Hindu : Mission Shakti might have had one message for India, and another for the world India has entered an elite space club with the Defence Research and Development Organisation blowing up a satellite in a Low Earth Orbit into smithereens. Such Indian capability to take out moving objects has never really been in doubt: the DRDO announced it as early as in 2011. Indeed, India has been in the business of testing long-range missiles for years, although public attention on the space programme has been mostly on its civilian and scientific aspects. The military dimension, though always latent, had not seen a verifiable demonstration as in the case of Mission Shakti, the Anti-Satellite (ASAT) missile test. The display of technological prowess through the test accentu
HIV remission achieved through stem cell transplantation

HIV remission achieved through stem cell transplantation

Health, Technology
Updates from :  the Hindu : At present, this is possible only if people living with HIV also have some form of cancer In a significant development, a person with HIV infection has been reported to be experiencing remission for the last 18 months after antiretroviral therapy (ART) was stopped following stem-cell transplantation in London. Remission is when HIV RNA (ribonucleic acid) is undetectable in blood. ART is used for treating HIV. The person with HIV was diagnosed with advanced Hodgkin’s lymphoma, a form of cancer, in 2012. To treat the cancer, stem cells which give rise to blood cells were transplanted from a donor who had two mutant copies of a co-receptor for HIV infection. This exercise was carried out in London. The co-receptor (CCR5) is used by the HIV virus to gain
ViBESolutions (P) Ltd | Technopark Campus| Thiruvananthapuram, Kerala 695581 | www.vibesolution.com | Designed by Vibesolutions.